Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Homologous Recombination02:31

Homologous Recombination

50.7K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

2.9K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Dimeric Rocaglate Promotes Multivalent eIF4A-RNA Assembly.

bioRxiv : the preprint server for biology·2026
Same author

Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma.

Cancers·2026
Same author

Dominant clones leverage developmental epigenomic states to drive ependymoma.

Nature·2026
Same author

Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers.

bioRxiv : the preprint server for biology·2026
Same author

Dissecting FOXA1 pioneering function by acute pharmacological degradation.

bioRxiv : the preprint server for biology·2026
Same author

High-throughput ligand diversification to discover chemical inducers of proximity.

Nature chemical biology·2026

相关实验视频

Updated: Jul 22, 2025

Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique
09:14

Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique

Published on: January 14, 2016

9.2K

在HDAC1和HDAC2之间的附带死亡率利用了癌症特异性的NuRD复合体脆弱性.

Yuxiang Zhang1, David Remillard1, Ugoma Onubogu2

  • 1Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.

Nature structural & molecular biology
|July 24, 2023
PubMed
概括

基脱乙酶1 (HDAC1) 和HDAC2对应物表现出合成杀伤性,提供治疗窗口. 在神经母细胞瘤等缺乏HDAC1的癌症中准HDAC2通过降低NuRD复合体来抑制瘤生长.

更多相关视频

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

8.6K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

458

相关实验视频

Last Updated: Jul 22, 2025

Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique
09:14

Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique

Published on: January 14, 2016

9.2K
Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

8.6K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

458

科学领域:

  • 癌症生物学 癌症生物学
  • 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
  • 分子瘤学分子瘤学

背景情况:

  • 转录协调剂被追求作为癌症药物点,但必需蛋白质限制了治疗选择.
  • 基因脱乙酶1 (HDAC1) 和HDAC2对于基因调节和细胞存活至关重要.
  • 癌症中经常出现的染色体缺失会在重要的基因通路中产生脆弱性.

研究的目的:

  • 为了识别和描述HDAC1和HDAC2对应物之间的合成致命性相互作用.
  • 探索针对这种HDAC1/2合成致死性癌症的治疗潜力.
  • 阐明HDAC1/2合成致死性背后的分子机制及其对癌症依赖性的影响.

主要方法:

  • 基因相互作用分析以确定HDAC1和HDAC2.2之间的合成致死性.
  • 利用基因破坏和dTAG介导的蛋白质降解来准HDAC2.2.
  • 研究HDAC2向对核细胞重塑和脱乙酶 (NuRD) 复合体和染色质可访问性的影响.
  • 分析神经母细胞瘤和多发性骨髓瘤中的癌症依赖性.

主要成果:

  • HDAC1和HDAC2表现出附带合成杀伤性,其中一个对象的半性删除与另一个对象的删除具有致命性.
  • 在HDAC1-缺乏神经母细胞瘤中准HDAC2抑制了瘤生长在体外和体内.
  • HDAC2的降解导致NuRD复合体成员的降解,减少染色质可访问性和转录受损.
  • 确定了NuRD复杂子单元作为神经母细胞瘤和多发性髓瘤的依赖性.

结论:

  • HDAC1/2附带合成致死性为具有特定染色体缺失的癌症提供了一个新的治疗点.
  • 有针对性的HDAC2降解提供了一种利用这种合成致死性和影响NuRD相关癌症依赖性的策略.
  • 开发对等选择性HDAC1或HDAC2降解剂可以利用这种癌症治疗的脆弱性.